IASO Biotechnology has received US Food and Drug Administration clearance for the Investigational New Drug application o...
Switzerland based Tenthpin Management Consultants, a global leader in management and technology consulting for Life Scie...
Teijin Limited, Teijin Regenet Co., Ltd., and Shinshu University Hospital have entered into a joint research agreement r...
As cell therapies advance towards greater clinical sophistication and commercial scale, the focus is shifting fr...
Andelyn Biosciences has partnered with Queen’s University to develop and manufacture AAV9-GM2, an investigational ...
Researchers from A*STAR have identified spatial differences in early brain development that could help explain why autis...
In conversation with BioSpectrum Asia, Laurie Masiello and John Masiello, Co-Founders of Predictive Monitor, explore how...
Australia is rapidly evolving beyond its reputation as a destination for early-stage clinical trials to build a more com...
IASO Biotechnology has completed its acquisition of Singapore-based MediSix Therapeutics, expanding its international ce...
Asia's biopharmaceutical manufacturing sector is entering a new phase of growth, driven by expanding biologics pipelines...
The next generation of cell and gene therapies is pushing manufacturing beyond the limits of conventiona...
Cell therapy is approaching a defining transition: from highly specialised science to a reproducible, scalable pharmaceu...
As gene therapy moves from scientific promise towards a new phase of commercial maturity, manufacturing has emerged as o...
As cell and gene therapies progress from promising research to commercial reality, manufacturing has emerged as ...
The rapid expansion of in vivo gene therapy is reshaping expectations for viral vector manufacturing, placing greater em...
ADCs continue to represent a major growth area for drug developers, with the market projected to reach $69B by 20291. As...
China-based CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that as...
As artificial intelligence reshapes the future of genomic medicine, WhiteLab Genomics is positioning itself at t...
The RNA revolution is entering a new chapter. While mRNA transformed the industry's perception of nucleic acid therapeut...
As cell and gene therapies move from clinical promise to commercial reality, the industry is increasingly recognising th...
Cell and gene therapies have transformed the treatment landscape for complex diseases, yet scaling these innovations bey...
As cell and gene therapies advance toward commercial reality, the industry's focus is rapidly shifting beyond manufactur...
Iovance Biotherapeutics, Inc., a US-based biotechnology company focused on innovating, developing, and delivering novel ...
Cell and gene therapy developers continue to face mounting pressure to improve manufacturing efficiency while maintainin...
Regenerative medicine is steadily redefining the future of cardiovascular care, with cell based therapies moving beyond ...
